Skip to main content
Caplight Logo









LAPIX Therapeutics

LAPIX Therapeutics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://lapix.com/

Last Round

Series A

Aug 5, 2024

Total Funding Raised

$11.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

LAPIX Therapeutics is a biopharmaceutical company that develops novel, orally bioavailable immune system restoration therapies for the treatment of autoimmune diseases and oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall-molecule drugsimmunomodulatorsdrug discoveryautoimmune diseaseimmune toleranceTIM pathwayclinical trialsoncology therapeuticsbiotech startupdrug pipelineinflammatory bowel diseaseIBDtherapeutic candidate

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LAPIX Therapeutics Comparables

Compare LAPIX Therapeutics with similar companies based on industry and business-model similarity.

LAPIX Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anokion
78%
Treg Therapeutics
78%
Merck & Co., Inc.
72%

LAPIX Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 5, 2024
Series AApr 27, 2023
SeedOct 18, 2022
SeedAug 23, 2022

Key People

Founding team and executive leadership

Anas Fathallah

Co-Founder And CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 1056% MoM, from 178 to 2.1K.

  • Oct 18, 2022

    $3.2M raised in Seed round.

LAPIX Therapeutics Filings

Explore SEC and related filing metadata, where available.

LAPIX Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LAPIX Therapeutics's valuation, stock price, and market status.

Is LAPIX Therapeutics a public or private company?

LAPIX Therapeutics is a private company.

What is the current stock price of LAPIX Therapeutics?

LAPIX Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is LAPIX Therapeutics worth (valuation)?

Valuation information for LAPIX Therapeutics is not publicly available.

Can I buy LAPIX Therapeutics stock?

LAPIX Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LAPIX Therapeutics's last funding round?

LAPIX Therapeutics's most recent funding round was Series A on April 13, 2023.

Who are the main investors in LAPIX Therapeutics?

Investor information for LAPIX Therapeutics is not publicly disclosed.

Will LAPIX Therapeutics IPO soon?

No public IPO plans have been announced for LAPIX Therapeutics.

How can I track LAPIX Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LAPIX Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range10
Year Founded2019
Last FundingAug 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?